Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market
DO Dow Jones Newswires Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market 6/30/2026, 01:00 PM GMT+8 Dow Jones Newswires SH SHILPAMED OR ORNAV Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market Market News Moneycontrol Shilpa Medicare enters monetisation phase, after years of investments R&D, manufacturing Reuters Shilpa Medicare Unit Enters Co-Development And Supply Agreement With Orion Corporation CNBC TV18 Shilpa Medicare shares gain 5% after arm partners with Orion Corp for cancer treatment drug Reuters Orion Pharma Announces Deal With Shilpa Medicare For Nivolumab Biosimilar
DO Dow Jones Newswires 
